Literature DB >> 19293372

Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.

Jana M Weiss1, Patrik L Andersson, Marja H Lamoree, Pim E G Leonards, Stefan P J van Leeuwen, Timo Hamers.   

Abstract

Due to their unique surfactant properties, poly- and perfluorinated compounds (PFCs) have been extensively used and can be found all over the environment. Concern about their environmental fate and toxicological properties has initiated several research projects. In the present study, we investigated if PFCs can compete with thyroxine (T(4), i.e., the transport form of thyroid hormone) for binding to the human thyroid hormone transport protein transthyretin (TTR). Such competitive capacity may lead to decreased thyroid hormone levels as previously reported for animals exposed to PFCs. Twenty-four PFCs, together with 6 structurally similar natural fatty acids, were tested for binding capacity in a radioligand-binding assay. The binding potency decreased in the order: perfluorohexane sulfonate > perfluorooctane sulfonate/perfluorooctanoic acid > perfluoroheptanoic acid > sodium perfluoro-1-octanesulfinate > perfluorononanoic acid, with TTR binding potencies 12.5-50 times lower than the natural ligand T(4). Some lower molecular weight compounds with structural similarity to these PFCs were > 100 times less potent than T(4). Simple descriptors based on the two-dimensional molecular structures of the compounds were used to visualize the chemical variation and to model the structure-activity relationship for the competitive potencies of the TTR-binding compounds. The models indicated the dependence on molecular size and functional groups but demanded a more detailed description of the chemical properties and data for validation and further quantitative structure-activity relationship (QSAR) development. Competitive binding of PFCs to TTR, as observed for human TTR in the present study, may explain altered thyroid hormone levels described for PFC-exposed rats and monkeys. Median human blood levels of the most potent TTR-binding PFCs are one to two orders of magnitude lower than concentration at 50% inhibition (IC(50)) values determined in the present study. In addition, this study contributes to the understanding of the bioaccumulation of PFCs in man and possibly in other wildlife species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293372     DOI: 10.1093/toxsci/kfp055

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  61 in total

1.  Characterization of non-radiolabeled Thyroxine (T4) uptake in cryopreserved rat hepatocyte suspensions: Pharmacokinetic implications for PFOA and PFOS chemical exposure.

Authors:  Julian Selano; Vicki Richardson; John Washington; Chris Mazur
Journal:  Toxicol In Vitro       Date:  2019-03-28       Impact factor: 3.500

2.  Perfluoroalkyl and polyfluoroalkyl substances and fetal thyroid hormone levels in umbilical cord blood among newborns by prelabor caesarean delivery.

Authors:  Ruxianguli Aimuzi; Kai Luo; Qian Chen; Hui Wang; Liping Feng; Fengxiu Ouyang; Jun Zhang
Journal:  Environ Int       Date:  2019-06-20       Impact factor: 9.621

3.  Exposure to perfluoroalkyl substances and associations with serum thyroid hormones in a remote population of Alaska Natives.

Authors:  Samuel C Byrne; Pamela Miller; Samarys Seguinot-Medina; Vi Waghiyi; C Loren Buck; Frank A von Hippel; David O Carpenter
Journal:  Environ Res       Date:  2018-06-27       Impact factor: 6.498

4.  Levels of perfluorinated compounds in human breast milk in Jordan: the impact of sociodemographic characteristics.

Authors:  Nihaya A Al-sheyab; Khaled M Al-Qudah; Yahya R Tahboub
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-24       Impact factor: 4.223

5.  Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.

Authors:  Maria H Harris; Emily Oken; Sheryl L Rifas-Shiman; Antonia M Calafat; Xiaoyun Ye; David C Bellinger; Thomas F Webster; Roberta F White; Sharon K Sagiv
Journal:  Environ Int       Date:  2018-04-26       Impact factor: 9.621

Review 6.  Recent developments in polyfluoroalkyl compounds research: a focus on human/environmental health impact, suggested substitutes and removal strategies.

Authors:  John Baptist Nzukizi Mudumbi; Seteno Karabo Obed Ntwampe; Tandi Matsha; Lukhanyo Mekuto; Elie Fereche Itoba-Tombo
Journal:  Environ Monit Assess       Date:  2017-07-18       Impact factor: 2.513

Review 7.  Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes.

Authors:  Zeyan Liew; Houman Goudarzi; Youssef Oulhote
Journal:  Curr Environ Health Rep       Date:  2018-03

8.  Perfluoroalkyl substances and thyroid function in older adults.

Authors:  Srishti Shrestha; Michael S Bloom; Recai Yucel; Richard F Seegal; Qian Wu; Kurunthachalam Kannan; Robert Rej; Edward F Fitzgerald
Journal:  Environ Int       Date:  2014-12-05       Impact factor: 9.621

9.  Fluorescence spectroscopic and calorimetry based approaches to characterize the mode of interaction of small molecules with DNA.

Authors:  Amrita Banerjee; Jasdeep Singh; Dipak Dasgupta
Journal:  J Fluoresc       Date:  2013-03-15       Impact factor: 2.217

10.  Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor.

Authors:  Manhai Long; Mandana Ghisari; Eva Cecilie Bonefeld-Jørgensen
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-29       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.